Collegium Pharmaceutical (COLL) Accounts Payables (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Accounts Payables of $6.8 million for Q1 2026, down 61.75% year-over-year from $17.9 million in Q1 2025, and down 35.94% quarter-over-quarter from $10.7 million in Q4 2025.
Collegium Pharmaceutical (COLL) Accounts Payables (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Accounts Payables history runs 13 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 61.75% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $6.8 million (down 61.75% YoY), while the FY2025 annual figure was $10.7 million, up 170.95% from the prior year.
- Accounts Payables for Q1 2026 stood at $6.8 million, down from $10.7 million in the prior quarter.
- The five-year high for Accounts Payables was $17.9 million in Q1 2025, with the low at $2.4 million in Q2 2024.
- The 5-year median for Accounts Payables is $6.0 million (2024), against an average of $6.4 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables slumped 63.48% in 2023, then jumped 351.49% in 2025.
- Collegium Pharmaceutical's Accounts Payables stood at $3.5 million in 2022, then jumped by 148.77% to $8.7 million in 2023, then tumbled by 54.74% to $3.9 million in 2024, then jumped by 170.95% to $10.7 million in 2025, then slumped by 35.94% to $6.8 million in 2026.
- Business Quant data shows COLL's Accounts Payables at $6.8 million in Q1 2026, $10.7 million in Q4 2025, and $7.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 356.00 Mn |
| 10 | Collegium Pharmaceutical | 887.15 Mn | 737.84 Mn | 110.29 Mn | 9.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.24 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Dec 31, 2025 | 10.66 Mn |
| Sep 30, 2025 | 7.65 Mn |
| Jun 30, 2025 | 10.89 Mn |
| Mar 31, 2025 | 17.85 Mn |
| Dec 31, 2024 | 3.93 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 2.41 Mn |
| Mar 31, 2024 | 6.02 Mn |
| Dec 31, 2023 | 8.69 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Mar 31, 2023 | 2.99 Mn |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 7.64 Mn |
| Jun 30, 2022 | 6.63 Mn |
| Mar 31, 2022 | 3.85 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | 7.73 Mn |